P55PIK transcriptionally activated by MZF1 promotes colorectal cancer cell proliferation

BioMed Research International

Volumn 2013, Issue , 2013, Pages

  Deng, Yu ^a   Wang, Jing ^b   Wang, Guihua ^a   Jin, Yuan ^a   Luo, Xuelai ^a   Xia, Xianmin ^a   Gong, Jianping ^a   Hu, Junbo ^a  

^a HUAZHONG UNIVERSITY OF SCIENCE AND TECHNOLOGY   (China)

^b HUAZHONG UNIVERSITY OF SCIENCE AND TECHNOLOGY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

ANTHRACYCLINE; DOXORUBICIN; MYELOID ZINC FINGER 1; PHOSPHATIDYLINOSITOL 3 KINASE; PHOSPHATIDYLINOSITOL 3 KINASE P55; UNCLASSIFIED DRUG; ZINC FINGER PROTEIN; KRUPPEL LIKE FACTOR; MZF1 PROTEIN, HUMAN; PIK3R3 PROTEIN, HUMAN; RETINOBLASTOMA PROTEIN; SMALL INTERFERING RNA;

ARTICLE; CANCER GROWTH; CELL PROLIFERATION; CHROMATIN IMMUNOPRECIPITATION; COLORECTAL CANCER; GENETIC TRANSCRIPTION; HUMAN; HUMAN CELL; MITOCHONDRION; PROTEIN EXPRESSION; BINDING SITE; COLORECTAL TUMOR; GENE EXPRESSION REGULATION; GENETICS; METABOLISM; PROMOTER REGION; REPORTER GENE; SITE DIRECTED MUTAGENESIS; TUMOR CELL LINE;

BINDING SITES; CELL LINE, TUMOR; CELL PROLIFERATION; COLORECTAL NEOPLASMS; GENE EXPRESSION REGULATION, NEOPLASTIC; GENES, REPORTER; HUMANS; KRUPPEL-LIKE TRANSCRIPTION FACTORS; MUTAGENESIS, SITE-DIRECTED; PHOSPHATIDYLINOSITOL 3-KINASES; PROMOTER REGIONS, GENETIC; RETINOBLASTOMA PROTEIN; RNA, SMALL INTERFERING;

EID: 84874630936     PISSN: 23146133     EISSN: 23146141     Source Type: Journal    
DOI: 10.1155/2013/868131     Document Type: Article

References (31)

1. Manning B. D., Cantley L. C., AKT/PKB signaling: navigating downstream. Cell 2007 129 7 1261 1274 2-s2.0-34250788809 10.1016/j.cell.2007.06.009 (Pubitemid 46962095)
2. Engelman J. A., Luo J., Cantley L. C., The evolution of phosphatidylinositol 3-kinases as regulators of growth and metabolism. Nature Reviews Genetics 2006 7 8 606 619 2-s2.0-33746257209 10.1038/nrg1879 (Pubitemid 44100518)
3. Vivanco I., Sawyers C. L., The phosphatidylinositol 3-kinase-AKT pathway in human cancer. Nature Reviews Cancer 2002 2 7 489 501 2-s2.0-0036632368 (Pubitemid 37328931)
4. Cantley L. C., The phosphoinositide 3-kinase pathway. Science 2002 296 5573 1655 1657 2-s2.0-0037205048 10.1126/science.296.5573.1655 (Pubitemid 34579158)
5. Foukas L. C., Berenjeno I. M., Gray A., Khwaja A., Vanhaesebroeck B., Activity of any class IA PI3K isoform can sustain cell proliferation and survival. Proceedings of the National Academy of Sciences of the United States of America 2010 107 25 11381 11386 2-s2.0-77954903710 10.1073/pnas.0906461107
6. Zhao L., Vogt P. K., Class I PI3K in oncogenic cellular transformation. Oncogene 2008 27 41 5486 5496 2-s2.0-51849128358 10.1038/onc.2008.244
7. Fruman D. A., Regulatory subunits of class IA PI3K. Current Topics in Microbiology and Immunology 2010 346 225 244 2-s2.0-79952112367
8. Pons S., Asano T., Glasheen E., Miralpeix M., Zhang Y., Fisher T. L., Myers M. G., Xiao Jian Sun, White M. F., The structure and function of p55(PIK) reveal a new regulatory subunit for phosphatidylinositol 3-kinase. Molecular and Cellular Biology 1995 15 8 4453 4465 2-s2.0-0028982198
9. Xia X., Cheng A., Akinmade D., Hamburger A. W., The N-terminal 24 amino acids of the p55 gamma regulatory subunit of phosphoinositide 3-kinase binds Rb and induces cell cycle arrest. Molecular and Cellular Biology 2003 23 5 1717 1725 2-s2.0-0037369896 10.1128/MCB.23.5.1717-1725.2003 (Pubitemid 36246052)
10. Hu J., Xia X., Cheng A., Wang G., Luo X., Reed M. F., Fojo T., Oetting A., Gong J., Yen P. M., A peptide inhibitor derived from p55PIK phosphatidylinositol 3-kinase regulatory subunit: a novel cancer therapy. Molecular Cancer Therapeutics 2008 7 12 3719 3728 2-s2.0-57749095656 10.1158/1535-7163.MCT-08-0499
11. Ferecatu I., Le Floch N., Bergeaud M., Rodríguez-Enfedaque A., Rincheval V., Oliver L., Vallette F. M., Mignotte B., Vayssière J. L., Evidence for a mitochondrial localization of the retinoblastoma protein. BMC Cell Biology 2009 10, article 50 2-s2.0-67651113436 10.1186/1471-2121-10-50
12. Zhang L., Huang J., Yang N., Greshock J., Liang S., Hasegawa K., Giannakakis A., Poulos N., O'Brien-Jenkins A., Katsaros D., Butzow R., Weber B. L., Coukos G., Integrative genomic analysis of phosphatidylinositol 3′-kinase family identifies PIK3R3 as a potential therapeutic target in epithelial ovarian cancer. Clinical Cancer Research 2007 13 18 5314 5321 2-s2.0-34848891922 10.1158/1078-0432.CCR-06-2660 (Pubitemid 47510355)
13. Soroceanu L., Kharbanda S., Chen R., Soriano R. H., Aldape K., Misra A., Zha J., Forrest W. F., Nigro J. M., Modrusan Z., Feuerstein B. G., Phillips H. S., Identification of IGF2 signaling through phosphoinositide-3-kinase regulatory subunit 3 as a growth-promoting axis in glioblastoma. Proceedings of the National Academy of Sciences of the United States of America 2007 104 9 3466 3471 2-s2.0-33847647117 10.1073/pnas.0611271104 (Pubitemid 46364182)
14. Mallory J. C., Crudden G., Oliva A., Saunders C., Stromberg A., Craven R. J., A novel group of genes regulates susceptibility to antineoplastic drugs in highly tumorigenic breast cancer cells. Molecular Pharmacology 2005 68 6 1747 1756 2-s2.0-27844595380 10.1124/mol.105.016519 (Pubitemid 41656027)
15. Hu J., Chai Y., Wang Y., Kheir M. M., Li H., Yuan Z., Wan H., Xing D., Lei F., Du, PI3K p55 γ promoter activity enhancement is involved in the anti-apoptotic effect of berberine against cerebral ischemia-reperfusion. European Journal of Pharmacology 2012 674 2-3 132 142
16. Kallin A., Johannessen L. E., Cani P. D., Marbehant C. Y., Essaghir A., Foufelle F., Ferré P., Heldin C. H., Delzenne N. M., Demoulin J. B., SREBP-1 regulates the expression of heme oxygenase 1 and the phosphatidylinositol-3 kinase regulatory subunit p55 γ Journal of Lipid Research 2007 48 7 1628 1636 2-s2.0-34548181395 10.1194/jlr.M700136-JLR200 (Pubitemid 47312024)
17. Tsai K. N., Chan E. C., Tsai T. Y., Chen K. T., Chen C. Y., Hung K., Cytotoxic effect of recombinant mycobacterium tuberculosis CFP-10/ESAT-6 protein on the crucial pathways of WI-38 cells. Journal of Biomedicine and Biotechnology 2009 2009 2-s2.0-68249147786 10.1155/2009/917084 917084
18. Luo X., Zhang X., Shao W., Yin Y., Zhou J., Crucial roles of MZF-1 in the transcriptional regulation of apomorphine-induced modulation of FGF-2 expression in astrocytic cultures. Journal of Neurochemistry 2009 108 4 952 961 2-s2.0-58549113002 10.1111/j.1471-4159.2008.05845.x
19. Morris J. F., Hromas R., Rauscher F. J., Characterization of the DNA-binding properties of the myeloid zinc finger protein MZF1: two independent DNA-binding domains recognize two DNA consensus sequences with a common G-rich core. Molecular and Cellular Biology 1994 14 3 1786 1795 2-s2.0-0028347522 (Pubitemid 24074573)
20. Aoyama T., Okamoto T., Fukiage K., Otsuka S., Furu M., Ito K., Jin Y., Ueda M., Nagayama S., Nakayama T., Nakamura T., Toguchida J., Histone modifiers, YY1 and p300, regulate the expression of cartilage-specific gene, chondromodulin-I, in mesenchymal stem cells. Journal of Biological Chemistry 2010 285 39 29842 29850 2-s2.0-77956915397 10.1074/jbc.M110.116319
21. Li J. R., Li J. G., Deng G. H., Zhao W. L., Dan Y. J., Wang Y. M., Chen S., A common promoter variant of TBX21 is associated with allele specific binding to Yin-Yang 1 and reduced gene expression. Scandinavian Journal of Immunology 2011 73 5 449 458 2-s2.0-79953064872 10.1111/j.1365-3083.2011.02520.x
22. Ratajewski M., Pulaski L., YY1-dependent transcriptional regulation of the human GDAP1 gene. Genomics 2009 94 6 407 413 2-s2.0-70449134642 10.1016/j.ygeno.2009.08.014
23. Lacaud G., Gore L., Kennedy M., Kouskoff V., Kingsley P., Hogan C., Carlsson L., Speck N., Palis J., Keller G., Runx1 is essential for hematopoietic commitment at the hemangioblast stage of development in vitro. Blood 2002 100 2 458 466 2-s2.0-0037100461 10.1182/blood-2001-12-0321 (Pubitemid 34761107)
24. Elagib K. E., Racke F. K., Mogass M., Khetawat R., Delehanty L. L., Goldfarb A. N., RUNX1 and GATA-1 coexpression and cooperation in megakaryocytic differentiation. Blood 2003 101 11 4333 4341 2-s2.0-0038819114 10.1182/blood-2002-09-2708 (Pubitemid 36857797)
25. Pine R., Constitutive expression of an ISGF2/IRF1 transgene leads to interferon- independent activation of interferon-inducible genes and resistance to virus infection. Journal of Virology 1992 66 7 4470 4478 2-s2.0-0026741769
26. Yarilina A., Park-Min K. H., Antoniv T., Hu X., Ivashkiv L. B., TNF activates an IRF1-dependent autocrine loop leading to sustained expression of chemokines and STAT1-dependent type I interferon-response genes. Nature Immunology 2008 9 4 378 387 2-s2.0-40949123747 10.1038/ni1576 (Pubitemid 351405107)
27. Chapman R. S., Duff E. K., Lourenco P. C., Tonner E., Flint D. J., Clarke A. R., Watson C. J., A novel role for IRF-1 as a suppressor of apoptosis. Oncogene 2000 19 54 6386 6391 2-s2.0-0034649495 10.1038/sj.onc.1204016 (Pubitemid 32641853)
28. Hromas R., Morris J., Cornetta K., Berebitsky D., Davidson A., Sha M., Sledge G., Rauscher F., Aberrant expression of the myeloid zinc finger gene, MZF-1, is oncogenic. Cancer Research 1995 55 16 3610 3614 2-s2.0-0029128430
29. Hromas R., Davis B., Rauscher F. J., Klemsz M., Tenen D., Hoffman S., Xu D., Morris J. F., Hematopoietic transcriptional regulation by the myeloid zinc finger gene, MZF-1. Current Topics in Microbiology and Immunology 1996 211 158 164 2-s2.0-0030050693 (Pubitemid 126540608)
30. Hsieh Y. H., Wu T. T., Huang C. Y., Hsieh Y. S., Liu J. Y., Suppression of tumorigenicity of human hepatocellular carcinoma cells by antisense oligonucleotide MZF-1. Chinese Journal of Physiology 2007 50 1 9 15 2-s2.0-34447636060
31. Mudduluru G., Vajkoczy P., Allgayer H., Myeloid zinc finger 1 induces migration, invasion, and in vivo metastasis through Axl gene expression in solid cancer. Molecular Cancer Research 2010 8 2 159 169 2-s2.0-77249096023 10.1158/1541-7786.MCR-09-0326